[go: up one dir, main page]

AU2003253329A1 - Molecular markers for cholangiolar carcinoma - Google Patents

Molecular markers for cholangiolar carcinoma

Info

Publication number
AU2003253329A1
AU2003253329A1 AU2003253329A AU2003253329A AU2003253329A1 AU 2003253329 A1 AU2003253329 A1 AU 2003253329A1 AU 2003253329 A AU2003253329 A AU 2003253329A AU 2003253329 A AU2003253329 A AU 2003253329A AU 2003253329 A1 AU2003253329 A1 AU 2003253329A1
Authority
AU
Australia
Prior art keywords
cholangiolar
carcinoma
molecular markers
markers
molecular
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003253329A
Inventor
Sabine Debuschewitz
Jurgen Jobst
Stephan Kaiser
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/EP2002/008305 external-priority patent/WO2003010336A2/en
Application filed by Individual filed Critical Individual
Publication of AU2003253329A1 publication Critical patent/AU2003253329A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G01N33/57525
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/112Disease subtyping, staging or classification
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/136Screening for pharmacological compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Hospice & Palliative Care (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2003253329A 2002-07-25 2003-07-25 Molecular markers for cholangiolar carcinoma Abandoned AU2003253329A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2002333275 2002-07-25
PCT/EP2002/008305 WO2003010336A2 (en) 2001-07-25 2002-07-25 Molecular markers for hepatocellular carcinoma
PCT/EP2003/008243 WO2004011945A2 (en) 2002-07-25 2003-07-25 Molecular markers for cholangiolar carcinoma

Publications (1)

Publication Number Publication Date
AU2003253329A1 true AU2003253329A1 (en) 2004-02-16

Family

ID=30775772

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003253329A Abandoned AU2003253329A1 (en) 2002-07-25 2003-07-25 Molecular markers for cholangiolar carcinoma

Country Status (3)

Country Link
EP (1) EP1525477A2 (en)
AU (1) AU2003253329A1 (en)
WO (1) WO2004011945A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5028615B2 (en) * 2006-05-24 2012-09-19 国立大学法人金沢大学 Detection of C-type cirrhosis and liver cancer by gene expression profile
US20140027283A1 (en) * 2010-12-10 2014-01-30 Mosaiques Diagnostics And Therapeutics Ag Method and marker for the diagnosis of a bile duct stricture and of a cholangiocellular carcinoma in bile

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002022746A (en) * 2000-07-12 2002-01-23 Kyokuho Yagita Early diagnostic method of cancer

Also Published As

Publication number Publication date
WO2004011945A3 (en) 2004-06-03
WO2004011945A2 (en) 2004-02-05
EP1525477A2 (en) 2005-04-27

Similar Documents

Publication Publication Date Title
AU2003294828A1 (en) Specific markers for pancreatic cancer
AU2002351828A1 (en) Novel genetic markers for leukemias
AU2003294503A1 (en) Molecular nephrotoxicology modeling
AU2001292802A1 (en) Genetic markers for tumors
AU2003258649A1 (en) High-density nrom-finfet
AU2003225523A1 (en) Functional pipelines
AU2003281287A1 (en) Toxicity markers
AU2003214981A1 (en) Molecular hepatotoxicology modeling
AU2003214438A1 (en) Providing location dependent information
AU2003291083A1 (en) Phenolic resins
AU2002951388A0 (en) Bookmark
AUPQ901700A0 (en) Molecular markers
AU2002245225A1 (en) Repeat-free probes for molecular cytogenetics
AU2003292064A1 (en) Rapid-assembly base
AU2003253329A1 (en) Molecular markers for cholangiolar carcinoma
AU2001255129A1 (en) Molecular markers
GB0326197D0 (en) Molecular marker
AU2003235768A1 (en) Molecular trichogram
AU2001275072A1 (en) Molecular marker for mitosis
EP1485406A4 (en) Highly homogeneous molecular markers for electrophoresis
AUPR470101A0 (en) A molecular marker
AU2003218924A1 (en) Luminescent markers
AU2003201037A1 (en) Highly functional polymers
AU2002333275A1 (en) Molecular markers for hepatocellular carcinoma
AU2003292197A1 (en) Lna-cpg conjugates

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase